Analysts at Jefferies Financial Group initiated coverage on shares of ArriVent BioPharma (NASDAQ:AVBP – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $35.00 price target on the stock. Jefferies Financial Group’s target price suggests a potential upside of 76.06% […]
ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 8 3% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.